A prototype-augmented graph representation learning framework for identifying brain disorder-associated genes and facilitating drug repurposing
PLOS Computational Biology · 2026
DOI: 10.1371/journal.pcbi.1014323 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2026. Verfasst von Jiafang Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Drug Repositioning, Brain Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, the Natural Science Foundation of China, Guangzhou Science and Technology Research Plan.
Abstract (Originalsprache)
Many genetic loci were identified as associated with neuropsychiatric disorders and neurodegenerative disorders by Genome-wide association studies (GWAS). How these loci impact these diseases is unclear. Advances in deep-learning approaches and multi-omics data have the potential to link GWAS findings with disease mechanisms. Here, we proposed the Multi-omics Graph Transformer Network (MOGT), a semi-supervised graph neural network that leverages graph representation learning to model biological networks derived from multi-omics data to predict disease-associated genes. MOGT outperforms the current approaches in disease gene prediction for two psychiatric disorders and three neurodegenerative/neurological diseases. High-risk genes (HRGs) for Parkinson’s disease (PD) predicted by MOGT were used to drug discovery by integrating with the CMAP database. Finally, 10 drugs were identified as potential candidates. Among them, the effect of drug UK-356618 was experimentally verified in a primary neuron model, showing that UK-356618 reversed the abnormal expression of PD-associated genes and improved the cell-level phenotypes of PD. Together, these results indicate that MOGT can be used to identify HRGs for brain disorders, and these predicted HRGs provide high-level insights into the mechanisms and treatments of brain disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangzhou, Guangdong, China.
- School of Computer Science and Engineering, Sun Yat-sen University, Guangzhou, Guangdong, China.
ORCID-Profile: Jiafang Li, Huiying Zhao
Förderung
- the National Key Research and Development Program of China
- the Natural Science Foundation of China
- Guangzhou Science and Technology Research Plan
- Natural Science Foundation of Guangdong
Zitieren
APA
Li, J., Li, Y., Lin, S., Rao, J., & Zhao, H. (2026). A prototype-augmented graph representation learning framework for identifying brain disorder-associated genes and facilitating drug repurposing. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1014323
Vancouver
Li J, Li Y, Lin S, Rao J, Zhao H. A prototype-augmented graph representation learning framework for identifying brain disorder-associated genes and facilitating drug repurposing. PLOS Computational Biology. 2026. doi:10.1371/journal.pcbi.1014323
BibTeX
@article{Li2026,
author = {Li, Jiafang and Li, Yifei and Lin, Siying and Rao, Jiahua and Zhao, Huiying},
title = {A prototype-augmented graph representation learning framework for identifying brain disorder-associated genes and facilitating drug repurposing},
journal = {PLOS Computational Biology},
year = {2026},
doi = {10.1371/journal.pcbi.1014323}
}
EUVIMED